Katkin Keith

CIK 00013145967 companiesIRVINE, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001314596

Recent Transactions

50 trades

Exercise/Conversion
Eledon Pharmaceuticals, Inc.$ELDN
Common Stock
2026-01-10+8,575→ 8,575 total
Exercise/Conversion
Eledon Pharmaceuticals, Inc.$ELDN
Restricted Stock Units
2026-01-10−8,575→ 0 total
Sale
Emergent BioSolutions Inc.$EBS
Common Stock
2025-05-23$6.30/sh−7,844→ 86,431 total
Purchase
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2025-05-19$9.11/sh+10,000→ 100,000 total
Award
Emergent BioSolutions Inc.$EBS
Stock Option (Right to Buy)
2025-04-30+15,824→ 41,572 total
Award
Emergent BioSolutions Inc.$EBS
Common Stock
2025-04-30+34,403→ 94,275 total
Award
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2025-02-05+25,000→ 90,000 total
Award
Eledon Pharmaceuticals, Inc.$ELDN
Restricted Stock Units
2025-01-10+8,575→ 8,575 total
Award
Eledon Pharmaceuticals, Inc.$ELDN
Stock Option (right to buy)
2025-01-10+77,175→ 77,175 total
Award
Emergent BioSolutions Inc.$EBS
Stock Option (Right to Buy)
2024-05-23+25,748→ 25,748 total
Award
Emergent BioSolutions Inc.$EBS
Common Stock
2024-05-23+17,430→ 59,872 total
Award
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2024-02-07+17,000→ 65,000 total
Award
Emergent BioSolutions Inc.$EBS
Common Stock
2023-05-25+33,847→ 42,442 total
Award
Eledon Pharmaceuticals, Inc.$ELDN
Stock Option (right to buy)
2023-05-01+752,185→ 752,185 total
Award
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2023-02-02+16,000→ 48,000 total
Award
Eledon Pharmaceuticals, Inc.$ELDN
Stock Option (right to buy)
2023-02-01+20,000→ 20,000 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Stock Options (Right to buy)
2022-10-06−20,782→ 0 total
Sale
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2022-10-06$25.90/sh−9,117→ 32,000 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Stock Options (Right to buy)
2022-10-06−9,117→ 0 total
Sale
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2022-10-06$25.90/sh−20,782→ 32,000 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2022-10-06$7.88/sh+20,782→ 52,782 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2022-10-06$8.93/sh+9,117→ 41,117 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Stock Options (Right to buy)
2022-10-04−223→ 0 total
Sale
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2022-10-04$25.00/sh−223→ 32,000 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Stock Options (Right to buy)
2022-10-04−137→ 0 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2022-10-04$8.93/sh+223→ 32,223 total
Sale
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2022-10-04$25.00/sh−137→ 32,000 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2022-10-04$7.88/sh+137→ 32,137 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2022-10-03$7.88/sh+167→ 32,167 total
Sale
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2022-10-03$25.00/sh−167→ 32,000 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Stock Options (Right to buy)
2022-10-03−13→ 0 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Stock Options (Right to buy)
2022-10-03−167→ 0 total
Sale
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2022-10-03$25.00/sh−13→ 32,000 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2022-10-03$8.93/sh+13→ 32,013 total
Sale
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2022-09-30$25.07/sh−647→ 32,000 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2022-09-30$7.88/sh+2,914→ 34,914 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Stock Options (Right to buy)
2022-09-30−2,914→ 0 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Stock Options (Right to buy)
2022-09-30−647→ 0 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2022-09-30$8.93/sh+647→ 32,647 total
Sale
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2022-09-30$25.07/sh−2,914→ 32,000 total
Award
Emergent BioSolutions Inc.$EBS
Common Stock
2022-04-02+8,595→ 8,595 total
Award
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2022-02-02+16,000→ 32,000 total
Award
Eledon Pharmaceuticals, Inc.$ELDN
Stock Option (right to buy)
2022-02-01+20,000→ 20,000 total
Award
RIGEL PHARMACEUTICALS INC$RIGL
Common Stock
2021-05-19+25,000→ 25,000 total
Award
RIGEL PHARMACEUTICALS INC$RIGL
Stock Option (Right to Buy)
2021-05-19+30,000→ 30,000 total
Award
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2021-02-03+16,000→ 16,000 total
Award
Eledon Pharmaceuticals, Inc.$ELDN
Stock Option (Right to Buy)
2020-09-11+5,907.15→ 5,907.15 total
Award
RIGEL PHARMACEUTICALS INC$RIGL
Stock Option (Right to Buy)
2020-05-15+55,000→ 55,000 total
Exercise/Conversion
Urovant Sciences Ltd.
Stock Option (Right to Buy)
2020-02-19+180,000→ 701,254 total
Tax Payment
Urovant Sciences Ltd.
Common Shares
2020-02-19$13.08/sh−104,788→ 274,892 total

Katkin Keith

Recent Transactions

Companies

Recent Filings

Address